Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial.
Authors: Hykin P; National Institute for Health Research, Moorfields Biomedical Research Centre, London, United Kingdom., Prevost AT; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, United Kingdom., Vasconcelos JC; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, United Kingdom., Murphy C; King's Clinical Trials Unit, King's Health Partners, King's College London, London, United Kingdom., Kelly J; King's Clinical Trials Unit, King's Health Partners, King's College London, London, United Kingdom., Ramu J; National Institute for Health Research, Moorfields Biomedical Research Centre, London, United Kingdom., Hounsome B; King's Clinical Trials Unit, King's Health Partners, King's College London, London, United Kingdom., Yang Y; Wolverhampton Eye Infirmary, Wolverhampton, United Kingdom., Harding SP; Eye and Vision Science, University of Liverpool, St Paul's Eye Unit, Royal Liverpool University Hospitals, Members of Liverpool Health Partners, Liverpool, United Kingdom., Lotery A; Department of Medicine, University of Southampton, Southampton, United Kingdom., Chakravarthy U; Biomedical Sciences, Queen's University of Belfast, Belfast, United Kingdom., Sivaprasad S; National Institute for Health Research, Moorfields Biomedical Research Centre, London, United Kingdom.
Corporate Authors: LEAVO Study Group
Source: JAMA ophthalmology [JAMA Ophthalmol] 2019 Nov 01; Vol. 137 (11), pp. 1256-1264.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6173
DOI:10.1001/jamaophthalmol.2019.3305